Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Biden proposes Medicaid, Medicare cover ...

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...

Shares in Amgen fell by double digits Tuesday on results for the company’s MariTide shot, which is viewed as a potential ...

A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...

The Department of Health and Human Services seeks to expand when Medicare and Medicaid can cover anti-obesity drugs, such as ...

As officials put the change in draft rules for 2026, the incoming president's Medicare agency pick might support it.

Wegovy is also approved in the U.K. and the U.S. to lower the risk of serious heart problems or strokes in overweight and ...